Back to MNKD Stock Lookup

MNKD – Corporate News

Apr 7, 2014 06:23 AM FDA Extends PDUFA Date for Mannkind's (MNKD) Afrezza
Apr 1, 2014 05:50 PM MannKind (MNKD): FDA Advisory Committee Recommends Approval of AFREZZA(R)
Apr 1, 2014 05:50 PM Mannkind (MNKD) Confirms FDA Panel Backs AFREZZA for Diabetes
Oct 14, 2013 09:25 AM MannKind (MNKD) Stock Higher after Resubmits AFREZZA NDA
Aug 14, 2013 05:12 PM Mannkind (MNKD) Working With Greenhill on Formal Partnering Process
Aug 14, 2013 06:15 AM MannKind (MNKD) AFREZZA Phase 3s Met Primary Endpoints in Type 1 & 2 Diabetes
Aug 14, 2013 06:14 AM MannKind Corp (MNKD) Reports Positive AFREZZA Phase 3 Results in Type 2 Diabetes
Jul 1, 2013 09:04 AM Mannkind (MNKD) Announces $160M Senior Notes Financing
Jun 17, 2013 09:19 AM MannKind (MNKD) Completes P-3 Study of AFREZZA
May 31, 2013 04:08 PM MannKind (MNKD) Completes Follow-Ups of AFREZZA Phase 3
Nov 13, 2012 08:09 AM Mannkind (MNKD) in License Deal with Colby Worth up to $140M
Oct 18, 2012 09:29 AM MannKind (MNKD) Prices 40M Common, 30M Warrants Offering
Oct 5, 2012 06:10 AM Mannkind (MNKD) Completes Patient Recruitment for AFREZZA
Apr 30, 2012 07:13 AM Tolero Pharma, MannKind (MNKD) Enter BTK Licensing Agreement; MannKind to Get $130M Upfront
Feb 3, 2012 06:51 AM MannKind (MNKD) Enters 31.25M Committed Purchase Agreement
Feb 3, 2012 06:50 AM MannKind (MNKD) Prices 31.25M Offering a $2.40/Unit
Sep 23, 2011 07:19 AM MannKind (MNKD) Announces $370M Senior Notes Offering
Aug 12, 2011 06:50 AM MannKind (MNKD) Confirms Two AFREZZA Studies with U.S. FDA
Apr 13, 2011 07:20 AM FDA Delays End-of-Review Meeting with MannKind (MNKD)
Apr 11, 2011 06:59 AM FDA Cancels End-of-Review Meeting with MannKind (MNKD)
Jan 19, 2011 05:45 PM MannKind (MNKD) Plummets 40% After FDA Requests More Trials for Insulin Inhaler
Nov 5, 2010 07:56 AM MannKind Corp. (MNKD) Issues Statement on Recent Lawsuit; "Arditi's Claims Have No Merit"
Oct 19, 2010 01:03 PM MannKind Corp. (MNKD) Initiates Phase 2 of MKC1106-MT
Aug 11, 2010 07:27 AM MannKind Corp. (MNKD) Enters 18.2M Common Purchase Commitment with Seaside 88
Jul 20, 2010 09:18 AM U.S. FDA Accepts MannKind's (MNKD) Submission of NDA for AREZZA, Classifies as Class 2 Resubmission
Jun 29, 2010 06:52 AM MannKind (MNKD) To Present Positive Data for AFREZZA in Patients with Type 2 Diabetes
Jun 10, 2010 10:33 AM MannKind (MNKD) Shows Promising Results in AFREZZA Study in Combo with Basal Insulin
Mar 29, 2010 09:09 AM MannKind (MNKD) and MMRF Announce Achievement of All Milestones for Development of New Multiple Myeloma Therapy
Mar 15, 2010 09:06 AM FDA Requests Additional Info Related to MannKind's (MNKD) AFREZZA(TM)
Mar 15, 2010 09:02 AM FDA requests additional information regarding MannKind's (MNKD) Afrezza
Mar 15, 2010 08:50 AM MannKind (MNKD) halted with news pending
Jan 11, 2010 08:21 AM BioCentury Publishes BioTech Picks for FY10 (HGSI, VRTX, AMGN, More...)
Oct 6, 2009 02:17 PM MannKind (MNKD) May See Weak 2010, Leerink Swann Analysts Think
Jun 22, 2009 09:07 AM MannKind (MNKD) Completes Acquisition of Insulin Assets from Pfizer (PFE)
Jun 8, 2009 08:17 AM MannKind's (MNKD) AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA
Mar 9, 2009 07:37 AM MannKind (MNKD) to Purchase Pfizer's (PFE) Frankfurt Insulin Manufacturing Plant for $33M
Dec 18, 2008 08:33 AM MannKind (MNKD) Reports Top-Line Results from 2 Phase 3 Studies of AFRESA(TM)
Dec 4, 2008 09:57 AM MannKind (MNKD) UP On Positive Results from Final Two Pivotal Phase 3 Clinical Studies
Sep 16, 2008 08:39 AM MannKind (MNKD) and Pfizer (PFE) Announce Collaboration for Certain Exubera Patients
Sep 16, 2008 08:03 AM MannKind (MNKD) Reports Preliminary Results from Phase 3 Study of Technosphere(R) Insulin System
May 5, 2008 03:09 PM The Leukemia & Lymphoma Society and MannKind Corporation (MNKD) Announce Collaborative Research Agreement
Apr 9, 2008 09:24 AM Nektar Therapeutics (NKTR) Fall Likely To Hurt Mannkind Corp (MNKD)
Mar 10, 2008 02:02 PM MannKind (MNKD) Issues Statement Regarding Recent Market Events
Oct 2, 2007 01:55 PM MannKind (MNKD) Raises $250M In Direct Offerings of Common Stock

Back to MNKD Stock Lookup